Lisata Therapeutics, Inc. Profile Avatar - Palmy Investing

Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient …

Biotechnology
US, Basking Ridge [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Lisata Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Lisata Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Lisata Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of LSTA's Analysis
CIK: - CUSIP: 128058302 ISIN: US1280583022 LEI: - UEI: -
Secondary Listings
LSTA has no secondary listings inside our databases.